These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29652176)

  • 1. Medication Use in Women and Men With Sudden Unexpected Death.
    Patel S; Conover MM; Joodi G; Chen S; Simpson RJ; Deyo ZM
    Ann Pharmacother; 2018 Sep; 52(9):868-875. PubMed ID: 29652176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program.
    Valle JA; O'Donnell CI; Armstrong EJ; Bradley SM; Maddox TM; Ho PM
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27184399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP; Alexander KP; Lytle B; Heiss G; Peterson ED
    Am Heart J; 2006 Jan; 151(1):185-91. PubMed ID: 16368315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-reporting of sudden unexpected death in epilepsy.
    Chen S; Joodi G; Devinsky O; Sadaf MI; Pursell IW; Simpson RJ
    Epileptic Disord; 2018 Aug; 20(4):270-278. PubMed ID: 30078774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-prescribing of cardiovascular therapies for diabetes in primary care.
    Bennett KE; Williams D; Feely J
    Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
    Ladapo JA; Hoffmann U; Lee KL; Coles A; Huang M; Mark DB; Dolor RJ; Pelberg RA; Budoff M; Sigurdsson G; Severance HW; Douglas PS
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27733347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
    Nguyen T; Nguyen HQ; Widyakusuma NN; Nguyen TH; Pham TT; Taxis K
    BMJ Open; 2018 Jan; 8(1):e018271. PubMed ID: 29326185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
    Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
    Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed Opportunities for Prevention of Sudden Death.
    Husain A; Masoudi EA; Mirzaei M; Joodi G; Sadaf MI; Lin FC; Simpson RJ
    N C Med J; 2021; 82(2):95-99. PubMed ID: 33649122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.